A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.
An international team of researchers, led by The University of Melbourne, has found two new mammogram-based measures for breast cancer risk.
An international study has uncovered new evidence of the positive role of androgens in breast cancer treatment.
GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease.
The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University.
The National Strategic Action Plan for Blood Cancer aims to unite Australia towards the goal of zero lives lost to blood cancer by 2035.
Melbourne identical twins have joined a major new study investigating why only one twin in a pair develops breast cancer, or if both twins are diagnosed, why one twin does so earlier.
Daily coffee consumption has been associated with improved survival in patients with metastatic colorectal cancer, according to a study led by Dana-Farber Cancer Institute.
A new report has revealed the unseen burden of non-melanoma skin cancer in Australia.
Researchers at Macquarie University's Nanotechnology Laboratory have created a personalised, wearable UV-sensitive device that could help millions avoid skin cancer.
The treatment combines a state-of-the-art MRI imaging scanner and a linear accelerator to allow treatment specialists to see tumours and adapt treatment in real time.
QIMR Berghofer researchers have discovered why some melanoma patients do not respond well to immunotherapy.
Australian researchers have found that a groundbreaking test can improve the early detection of prostate cancer.
Each drug in the combination has a different mechanism of action to kill myeloma cells, and all work together to help fight the disease.
A team of researchers at The University of Queensland may have found a way to improve treatment of triple-negative breast cancer.